InfoMedics Presents Studies Highlighting Adults’ Experiences With ADHD Drug
InfoMedics, Inc., the patient feedback company, recently co-authored two posters detailing patients’ experiences with the attention-deficit/hyperactivity disorder (ADHD) drug lisdexamfetamine dimesylate (LDX). The posters were presented at the American Psychiatric Association (APA) and the College of Psychiatric and Neurologic Pharmacists’ (CPNP) annual meetings.
More: continued here
Filed under: ADHD on June 8th, 2009
You must be logged in to post a comment.